Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...